A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Conditions
Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Diffuse Large B Cell Lymphoma (DLBCL) · Follicular Lymphoma (FL) · Mantle Cell Lymphoma (MCL) · Marginal Zone Lymphoma (MZL) · Waldenstrom Macroglobulinemia (WM) · Primary Central Nervous System Lymphoma (PCNSL) · Secondary Central Nervous System Lymphoma (SCNSL)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope, Duarte, California, United States
University of California, San Francisco, San Francisco, California, United States
Colorado Blood Cancer Institute, Denver, Colorado, United States
Yale Cancer Center, New Haven, Connecticut, United States
University of Miami, Miami, Florida, United States
Florida Cancer Specialists, Sarasota, Florida, United States
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
Northwestern University, Chicago, Illinois, United States
National Institute of Health, Bethesda, Maryland, United States
Cayuga Medical Center, Ithaca, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Cleveland Clinic, Cleveland, Ohio, United States
University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States
MD Anderson Cancer Center, Houston, Texas, United States
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
CHU Angers, Angers, France
Hôpital Avicenne, Bobigny, France
CHU de Nantes, Nantes, France
CHU Bordeaux, Pessac, France
CHU de Poitiers, Poitiers, France
Institut Curie-Site Saint-Cloud, Saint-Cloud, France
CHRU de Nancy, Vandœuvre-lès-Nancy, France
IRCCS - AOU di Bologna, Bologna, Italy
ASST Spedali Civili Brescia, Brescia, Italy
IRCCS Ospedale San Raffaele - Università Vita-Salute San Raffaele di Milano, Milan, Italy
IRCCS Ospedale San Raffaele, Milan, Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
University Medical Center Groningen, Groningen, Netherlands
Radboud University Medical Center, Nijmegen, Netherlands
Erasmus MC, Rotterdam, Netherlands
University Medical Center Utrecht, Utrecht, Netherlands
AidPort sp. Zo.o, Skórzewo, Greater Poland Voivodeship, Poland
Pratia MCM, Krakow, Lesser Poland Voivodeship, Poland
University Clinical Hostpital in Wroclaw, Wroclaw, Lower Silesian Voivodeship, Poland
Pratia MTZ, Warsaw, Masovian Voivodeship, Poland
National Institute of Oncology Warszawa, Warsaw, Masovian Voivodeship, Poland
Pratia Onkologia Katowice, Katowice, Silesian Voivodeship, Poland
Medical University of Lublin, Lublin, Poland
Hospital Universitari Vall d'Hebron, Barcelona, Spain
Hospital Clínic de Barcelona, Barcelona, Spain
Hospital Universitario de Cabuenes, Gijón, Spain
Hospital Ramón y Cajal, Madrid, Spain
Hospital Fundación Jimenez Díaz - START Madrid, Madrid, Spain
Universitätsspital Basel, Basel, Switzerland
Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland
Inselspital - Universitatsklinik Bern, Bern, Switzerland
Hôpitaux Universitaires de Genève, Geneva, Switzerland
Kantonsspital St.Gallen, Sankt Gallen, Switzerland
University Hospital Zurich, Zurich, Switzerland
The Christie NHS Foundation Trust, Manchester, Manchester, United Kingdom
The Beatson WOS Cancer Center, Glasgow, Scotland, United Kingdom
St. James Hospital, Leeds, United Kingdom
Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, United Kingdom
St. Bartholomew's Hospital, Barts NHS Trust, London, United Kingdom
Sarah Cannon Research Institute UK, London, United Kingdom
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
Study leads
Study Director
Nurix Therapeutics, Inc.